TITLE

The significance of heparin-coated veno-venous bypass circuits in liver transplantation

AUTHOR(S)
Scholz, Tim; Solberg, Rigmor; Okkenhaug, Cecilie; Videm, Vibeke; Gallimore, Michael J; Mathisen, Øystein; Mollnes, Tom E; Bergan, Anstein; Søreide, Odd; Klintman, Göran B; Aasen, Ansgar O
PUB. DATE
January 2002
SOURCE
Perfusion;Jan2002, Vol. 17 Issue 1, p45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We studied the effects of veno-venous bypass (VVBP) circuit surface heparinization on the activation of the plasma defence systems (coagulation, fibrinolysis, kallikrein- kinin and complement) and leukocyte activation in a prospective randomized study in 20 patients during and 1 day after liver transplantation (OLT). To our knowledge, this is the first study of this kind where the possible benefits of surface heparinization of the VVBP circuit in OLT have been investigated. Twenty patients were randomized to either heparin-coated (HC) VVBP equipment or to otherwise identical noncoated (NC) circuits. Five blood samples were drawn during the OLT procedure: one just before VVBP, three during VVBP and one 5 min after portal venous reperfusion (PVR). A further sample was taken 1 day after the operation. Components of the blood coagulation, fibrinolytic and kallikrein-kinin systems were analysed using functional assays (chromogenic peptide substrate assays) or enzyme immunoassays (EIA). Complement system factors and granulocyte activation, represented by myeloperoxidase (MPO) release, were analyzed by EIA. Activation of the plasma defence systems occurred in both groups at an early stage during OLT and a further activation occurred 5 min after PVR. MPO levels were slightly elevated 5 min after PVR. However, no significant differences between the two groups were observed. Significant activation of the humoral defense systems was found in both groups during OLT. A considerably larger study, including at least 330 patients, is necessary to fully assess the possible benefits of surface heparinization of the VVBP circuit.
ACCESSION #
6567709

 

Related Articles

  • Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Tsang Lau; Ahmad, Jawad // Hepatic Medicine: Evidence & Research;2013, Vol. 5, p1 

    The Model for End-Stage Liver Disease (MELD) score incorporates serum bilirubin, creatinine, and the international normalized ratio (INR) into a formula that provides a continuous variable that is a very accurate predictor of 90-day mortality in patients with cirrhosis. It is currently utilized...

  • Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Collins, Katherine L.; Roberts, Eve A.; Adeli, Khosrow; Bohn, Desmond; Harvey, Elizabeth A. // Pediatric Nephrology;Jun2008, Vol. 23 Issue 6, p1013 

    Since fulminant Wilsonian liver failure has an extremely poor prognosis, the use of a liver support system that can bridge patients to liver transplant is life saving. We report here the case of a 17-year-old female who presented with fulminant Wilsonian liver failure and intravascular...

  • Transjugular Intrahepatic Portosystemic Shunt for Maintenance of Portal Venous Patency in Liver Transplant Candidates. Gaba, Ron Charles; Parvinian, Ahmad // Journal of Clinical Imaging Science;Jan-Mar2013, Vol. 3 Issue 1, p1 

    Maintenance of portal venous patency is vital to liver transplant candidates, as the presence of portal vein thrombosis (PVT) adversely impacts clinical outcomes by increasing surgical complexity and decreasing postoperative survival. By enhancing portal venous blood flow, transjugular...

  • Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation. Bihl, Florian; Russmann, Stefan; Gurtner, Vanina; Di Giammarino, Loriana; Pizzi-Bosman, Loredana; Michel, Martine; Cerny, Andreas; Hadengue, Antoine; Majno, Pietro; Giostra, Emiliano; Castelli, Damiano; Mentha, Gilles // BMC Gastroenterology;2010, Vol. 10, p71 

    Background: Hepatitis B immune globulins (HBIG) in combination with nucleos(t)ide analogues (NA) are effectively used for the prevention of hepatitis B virus (HBV) recurrence after liver transplantation (LT). However, associated treatment costs for HBIG are exceedingly high. Methods: Fresh...

  • Emergent Management of Intracardiac Thrombosis during Liver Transplantation. Protin, Caroline; Bezinover, Dmitri; Kadry, Zakiyah; Verbeek, Thomas // Case Reports in Transplantation;12/14/2016, p1 

    Intraoperative thromboembolism is a well-documented complication associated with orthotopic liver transplantation (OLT) but its identification and intraoperative treatment are still an emerging topic in anesthesia. Intracardiac thrombus during OLT is associated with a high mortality rate. There...

  • APTT in Heparinized Plasma: Influence of Reagent, Acute-Phase Reaction, and Interval Between Sampling and Testing. Strekerud, Finn G.; Abildgaard, Ulrich // Clinical & Applied Thrombosis/Hemostasis;Fall1996, Vol. 2 Issue 4, p250 

    Plasma samples from 10 healthy persons and 10 patients with acute-phase reaction were heparinized in vitro to obtain 0.00-0.70 U/ml. The activated partial thromboplastin time (aPTT) was then determined, using an optical method (Automated Coagulation Laboratory) and four reagents (actin,...

  • Acute intralipid infusion reduces cardiac luminal lipoprotein lipase but recruits additional enzyme from cardiomyocytes. Qi, Dake; Kuo, Kuo-Hsing; Abrahani, Ashraf; An, Ding; Qi, Yadan; Heung, Jessica; Kewalramani, Girish; Pulinilkunnil, Thomas; Ghosh, Sanjoy; Innis, Sheila M.; Rodrigues, Brian // Cardiovascular Research;Oct2006, Vol. 72 Issue 1, p124 

    Abstract: Objective: Lipoprotein lipase (LPL) metabolizes the triglyceride (TG) core of lipoproteins. We evaluated whether circulating lipids can regulate LPL by influencing the transfer of enzyme from the myocyte to the endothelial lumen. Methods: Acute intralipid (IL, 10% and 20%) infusion was...

  • Limitation of the Vitrosâ„¢ dry-slide technique in measuring high concentrations of salicylate in plasma. Iversen, S. A.; Walker, A.; Avades, T. Y.; Wilson, J. F. // Annals of Clinical Biochemistry;Nov2001, Vol. 38 Issue 6, p711 

    The linearity of the Vitrosâ„¢ dry-slide method for plasma salicylate was assessed in two ways: serial concentrations of sodium salicylate were added to fresh lithium heparin plasma, and the salicylate was determined both neat and in dilution. Vitros salicylate results submitted to the...

  • The low molecular weight heparin dalteparin for prophylaxis and therapy of thrombosis in childhood: a report on 48 cases. Nohe, N.; Flemmer, A.; Rümler, R.; Praun, M.; Auberger, K. // European Journal of Pediatrics;1999, Vol. 158 Issue 15, pS134 

    Abstract We investigated the efficacy, safety and relation of dose to plasma anti-Xa activity of the low molecular weight heparin (LMWH) dalteparin in prophylaxis and therapy of arterial and venous thrombosis in pediatric patients. A total of 48 children were enrolled: 10 received dalteparin for...

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics